TOLVAPTAN: A POSSIBLE PREEMPTIVE TREATMENT OPTION IN CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE?

Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?

Tolvaptan is a highly selective vasopressin receptor 2 antagonist that regulates cyclic KNIFE MAKING adenosine monophosphate levels to inhibit both epithelial cell proliferation and chloride ion excretion, two mechanisms known to induce cyst expansion in autosomal dominant polycystic kidney disease (ADPKD).Tolvaptan is currently the preferred treat

read more

A Systematic Investigation of Beam Losses and Position-Reconstruction Techniques Measured with a Novel oBLM at CLEAR

Optical Beam-Loss Monitors (oBLMs) allow for cost-efficient and spatially continuous measurements of beam losses at accelerator facilities.A standard oBLM consists of several tens of metres of optical fibre aligned parallel to a beamline, coupled to photosensors Oximeters at either or both ends.Using the timing information from loss signals, the lo

read more